287 related articles for article (PubMed ID: 7301457)
1. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
2. Age-related alterations of immunoreactive pancreatic cationic trypsinogen in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Durie PR; Forstner GG; Gaskin KJ; Moore DJ; Cleghorn GJ; Wong SS; Corey ML
Pediatr Res; 1986 Mar; 20(3):209-13. PubMed ID: 3703609
[TBL] [Abstract][Full Text] [Related]
3. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis.
Cleghorn G; Benjamin L; Corey M; Forstner G; Dati F; Durie P
Pediatrics; 1986 Mar; 77(3):301-6. PubMed ID: 3951910
[TBL] [Abstract][Full Text] [Related]
4. Plasma immunoreactive cationic trypsin(ogen) pattern in reserpinized rat model of cystic fibrosis. Resemblance to humans.
Weizman Z
Dig Dis Sci; 1996 May; 41(5):853-8. PubMed ID: 8625754
[TBL] [Abstract][Full Text] [Related]
5. Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
Durie PR; Gaskin KJ; Geokas MC; O'Rourke M; Largman C
J Pediatr Gastroenterol Nutr; 1982; 1(3):337-43. PubMed ID: 7186046
[TBL] [Abstract][Full Text] [Related]
6. Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome.
Weizman Z; Forstner GG; Gaskin KJ; Kopelman H; Wong S; Durie PR
Gastroenterology; 1985 Sep; 89(3):596-604. PubMed ID: 3874804
[TBL] [Abstract][Full Text] [Related]
7. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
8. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies.
Moore DJ; Largman C; Kopelman HR; Wong S; Durie PR
Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196
[TBL] [Abstract][Full Text] [Related]
9. Cystic fibrosis "factor(s)": present also in sera of Schwachman's pancreatic insufficiency.
Banchini G; Harries JT; Milla PJ; Muller DP; Roma E; Tripp JH
Pediatr Res; 1981 Jul; 15(7):1073-5. PubMed ID: 6265859
[TBL] [Abstract][Full Text] [Related]
10. Calcium-ATPase activity in cystic fibrosis erythrocyte membranes: decreased activity in patients with pancreatic insufficiency.
Dearborn DG; Wityk RJ; Johnson LR; Poncz L; Stern RC
Pediatr Res; 1984 Sep; 18(9):890-5. PubMed ID: 6091022
[TBL] [Abstract][Full Text] [Related]
11. [Serum cationic trypsinogen: marker of exocrine pancreatic dysfunction in children with protein-calorie malnutrition].
de Kolster CC; Kolster JG; Rached I; Estopiñán M; Azuaje M; Bordones G; Castro J; Carvajal A; Laurentin N
G E N; 1991; 45(2):92-7. PubMed ID: 1843944
[TBL] [Abstract][Full Text] [Related]
12. [Interest in pediatrics in the value of trypsin by the radioimmunologic method].
Carrel O; Felber JP; Gautier E
Helv Paediatr Acta; 1981 Nov; 36(5):405-16. PubMed ID: 7031021
[TBL] [Abstract][Full Text] [Related]
13. Effects of food intake and cholecystokinin on plasma trypsinogen levels in dogs.
Reidelberger RD; O'Rourke M; Durie PR; Geokas MC; Largman C
Am J Physiol; 1984 May; 246(5 Pt 1):G543-9. PubMed ID: 6326612
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive pancreatic Reg protein in sera from cystic fibrosis patients with and without pancreatic insufficiency.
Carrère J; Guy-Crotte O; Gaia E; Figarella C
Gut; 1999 Apr; 44(4):545-51. PubMed ID: 10075963
[TBL] [Abstract][Full Text] [Related]
15. [Determination of exocrine pancreatic function in childhood with the pancreozymin-secretin test].
Richter T; Müller D; Senger H; Beyreiss K
Kinderarztl Prax; 1992 Nov; 60(8):226-9. PubMed ID: 1281898
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis.
Moore DJ; Forstner GG; Largman C; Cleghorn GJ; Wong SS; Durie PR
Gut; 1986 Nov; 27(11):1362-8. PubMed ID: 3792918
[TBL] [Abstract][Full Text] [Related]
17. [Radio-immuno-assay for trypsin in newborn-screening for cystic fibrosis].
Sander J; Niehaus C
Monatsschr Kinderheilkd; 1982 Nov; 130(11):843-5. PubMed ID: 7155149
[TBL] [Abstract][Full Text] [Related]
18. Plasma immunoreactive-trypsin(ogen) levels during development.
Levine JJ; Udall JN; Bloch KJ; Hanson DG; James BC; Walker WA
J Pediatr Gastroenterol Nutr; 1988; 7(3):406-10. PubMed ID: 3260281
[TBL] [Abstract][Full Text] [Related]
19. Relation between serum cathodic trypsinogen levels and exocrine pancreatic function.
Andriulli A; Masoero G; Benitti V; Amato A; Piantino P; Gaia E
J Clin Gastroenterol; 1984 Jun; 6(3):239-44. PubMed ID: 6725915
[TBL] [Abstract][Full Text] [Related]
20. Immunoreactive trypsin(ogen) in the sera of children with recent-onset insulin-dependent diabetes and matched controls. The Swedish Childhood Diabetes Group.
Landin-Olsson M; Borgström A; Blom L; Sundkvist G; Lernmark A
Pancreas; 1990 May; 5(3):241-7. PubMed ID: 2188253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
